Jiangsu Jibeier Pharmaceutical Co. Ltd.

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: CNE100004041

CNY

28.88

0.12 (0.42%)

Dec 04

SHG

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangsu Jibeier Pharmaceutical Co. Ltd.

Why is Jiangsu Jibeier Pharmaceutical Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 11.56% and Operating profit at 13.55% over the last 5 years

Negative results in Mar 25

INTEREST(HY) At CNY 0.11 MM has Grown at 17.45%
INTEREST COVERAGE RATIO(Q) Lowest at 79,367.89

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangsu Jibeier Pharmaceutical Co. Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Jiangsu Jibeier Pharmaceutical Co. Ltd.

16.83%

0.48

41.33%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.56%

EBIT Growth (5y)

13.55%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.39

Sales to Capital Employed (avg)

0.41

Tax Ratio

13.72%

Dividend Payout Ratio

69.03%

Pledged Shares

Institutional Holding

ROCE (avg)

24.96%

ROE (avg)

9.21%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.49

EV to EBIT

21.26

EV to EBITDA

20.13

EV to Capital Employed

3.44

EV to Sales

5.46

PEG Ratio

23.77

Dividend Yield

2.49%

ROCE (Latest)

16.17%

ROE (Latest)

10.47%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -0.67% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 3.02%

-8What is not working for the Company

INTEREST(HY)

At CNY 0.11 MM has Grown at 17.45%

INTEREST COVERAGE RATIO(Q)

Lowest at 79,367.89

Here's what is working for Jiangsu Jibeier Pharmaceutical Co. Ltd.

Inventory Turnover Ratio

Highest at 3.02%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -0.67% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangsu Jibeier Pharmaceutical Co. Ltd.

Interest

At CNY 0.11 MM has Grown at 17.45%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 79,367.89

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest